Home› Funds› HSBC Fixed Term Series 129 - Direct Plan Growth Op

HSBC Fixed Term Series 129 - Direct Plan Growth Option

HSBC · Equity Fund
High
₹12.38
Current NAV
30 Jun 2020
8.0%
1Y Return
7.2%
3Y CAGR
12.5%
5Y CAGR
Watchlist
NAV History (1 Year)
Analysis & Suitability
Pros / Upsides
  • Highly cost-efficient with a low expense ratio of 0.85%.
  • Excellent risk-adjusted performance (Sharpe Ratio: 1.25).
  • Generates significant excess returns relative to benchmark index (Alpha: 2.75).
  • Very large asset base (AUM: ₹15,800 Cr) indicating high investor trust and liquidity.
Cons / Risks
  • Subject to high equity market volatility and short-term capital fluctuations.
  • Sluggish 3-year performance, lagging behind primary equity benchmarks.
Suitable for
  • Long-term wealth creation (5+ years horizon) like retirement or child education.
  • Systematic investments (SIP) for long-term target goal-based planning.
Not suitable for
  • Short-term goals (under 3 years) where preserving the capital is the main priority.
  • Short-term trading or speculative investment horizons.
Risk Profile: High Risk
Low Moderate High Very High
Risk Metrics
1.25
Sharpe Ratio
0.55
Beta
2.75
Alpha
1.56
Sortino
Fund Details
Fund House HSBC
Category Equity Fund
AUM ₹15800 Cr
Expense Ratio 0.85%
Min SIP ₹500
Min Lumpsum ₹1000
SIP Calculator Compare Funds
Similar Funds in Equity Fund
UTI Regular Saving Fund ( Segregated - 17022020) - Direct Plan - Flexi IDCW
UTI
₹3.41 339.0%
UTI - Regular Saving Fund (Segregated - 17022020) - Direct Plan - Monthly Payment Option
UTI
₹4.01 339.0%
UTI Regular Saving Fund ( Segregated - 17022020) - Direct Plan - Monthly IDCW
UTI
₹1.45 339.0%
UTI - Regular Saving Fund (Segregated - 17022020) - Direct Plan - Growth Option
UTI
₹4.08 339.0%